Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/22/2867237/24675/en/Fate-Therapeutics-Announces-Presentation-of-FT819-Proof-of-Concept-Data-for-B-cell-mediated-Autoimmune-Diseases-at-ASGCT-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/03/2856877/24675/en/Fate-Therapeutics-to-Present-at-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/04/02/2856454/24675/en/Fate-Therapeutics-Reports-New-Employee-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/03/19/2848583/24675/en/Fate-Therapeutics-Announces-Pricing-of-100-Million-Underwritten-Offering-and-Concurrent-Private-Placement.html
https://www.globenewswire.com//news-release/2024/03/05/2840880/24675/en/Fate-Therapeutics-Reports-New-Employee-Inducement-Award-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/03/01/2838787/24675/en/Fate-Therapeutics-to-Present-at-Upcoming-March-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/02/26/2835475/24675/en/Fate-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Business-Updates.html
https://www.globenewswire.com//news-release/2024/02/15/2829883/24675/en/Fate-Therapeutics-to-Webcast-Conference-Call-Reporting-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/02/2823042/24675/en/Fate-Therapeutics-Reports-New-Employee-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/01/08/2805394/24675/en/Fate-Therapeutics-Announces-Initiation-of-Phase-1-Clinical-Trial-for-FT825-ONO-8250-in-Patients-with-HER2-expressing-Advanced-Solid-Tumors.html